Our Master of Research (MRes) in Translational Medicine provides high-quality research and training skills for students who want to use state-of-the-art biotechnologies to rapidly translate disease research into improved clinical healthcare.
With advances in technology, graduates are now faced with heightened expectations to conduct effective bioscience research.
Employers demand skillsets comprising biological, medical, physical and computational characteristics and this Masters is designed to provide this breadth of training.
The core aim is to train the next generation of scientists able to 'fast-track' biological and scientific data into advanced therapies and diagnostics tools.
Our understanding of the molecular basis of disease and drug mechanisms has improved dramatically in recent years, yet there is a distinct shortage of individuals able to apply this knowledge into effective clinical benefit.
Our MRes in Translational Medicine (Interdisciplinary Molecular Medicine) provides intense training in 'omics' skills and techniques such as genetics, genomics, transcriptomics, proteomics and metabolomics.
The training in metabolomic techniques is novel for a UK course, and teaching on the integration of different omic platforms and data in a systems medicine strategy is unique.
With its extended 35-week research project and broad training in biotechnology for medical healthcare, this MRes provides an excellent platform to progress into PhD research, or for a career in academia or the pharmaceutical or biotechnology industries, or as a clinical academic.
The MRes has substantial interdisciplinary focus; training comprises four taught modules before you undertake an extended 35-week research project within The University of Manchester, Waters or one of the Greater Manchester teaching hospitals.
A wide choice of projects are available, allowing individuals to focus on areas of interest such as the use of gene expression profiling, proteomics, metabolomics, stem cell research, tissue culture or pharmacogenetics in the biology of cancer, cardiovascular disease, infectious diseases, stroke or diabetes.
The MRes lasts for one year full-time, so it provides the ideal opportunity to experience the challenges of multidisciplinary research first-hand before committing to further training.
Over 85% of our graduates secure further research (PhD), pharmaceutical or biotechnology industry, or medical training posts upon completion.
Our MRes, with its extended 35-week research project and broad training in biotechnology for medical healthcare, provides an excellent platform to progress into PhD research, or for a career in the pharmaceutical or biotechnology Industries or as a clinical academic.
-More than 50% of our graduates progress into PhD research (for example, within the Universities of Manchester, Cambridge, Imperial College London, Newcastle, Glasgow, Liverpool, Bristol).
-Around 15% pursue a career in the pharmaceutical or biotechnology industry in the UK or abroad.
-Approximately 25% are intercalating medics who complete their medical education.
-An estimated 10% pursue an undergraduate medical degree.